vimarsana.com

Page 17 - வீடு பெரும்பான்மை தலைவர் ஸ்டேனி News Today : Breaking News, Live Updates & Top Stories | Vimarsana

How Maine s members of Congress voted last week - Portland Press Herald

How Maine’s members of Congress voted last week Among other legislation, the House has passed the Comprehensive Debt Collection Improvement Act, which would enact various measures that regulate debt collection and restrict collection practices. Targeted News Service Share Along with the week’s roll call votes, the Senate also passed the Alaska Tourism Recovery Act (S. 593). HOUSE VOTES ORPHAN PRESCRIPTION DRUGS: The House has rejected the Fairness in Orphan Drug Exclusivity Act (H.R. 1629), sponsored by Rep. Madeleine Dean, D-Pa. The bill would have prevented prescription drug manufacturers who receive orphan status for a drug from the Food and Drug Administration from using the same status for a newly approved drug that has an ingredient identical to the drug that received orphan status. Dean said the change would help “ensure people can gain access to newer therapies and medically assisted treatments that are potentially blocked due to orphan designation.” The vote,

How Maine s members of Congress voted last week

Among other legislation, the House has passed the Comprehensive Debt Collection Improvement Act, which would enact various measures that regulate debt collection and restrict collection practices.

Congressional Votes: Waltz, Rutherford against regulating debt collection

Targeted News Service Here s a look at how area members of Congress voted over the previous week. Along with the week s roll call votes, the Senate also passed the Alaska Tourism Recovery Act (S. 593). HOUSE VOTES House Vote 1 ORPHAN PRESCRIPTION DRUGS: The House has rejected the Fairness in Orphan Drug Exclusivity Act (H.R. 1629), sponsored by Rep. Madeleine Dean, D-Pa. The bill would have prevented prescription drug manufacturers who receive orphan status for a drug from the Food and Drug Administration from using the same status for a newly approved drug that has an ingredient identical to the drug that received orphan status. Dean said the change would help ensure people can gain access to newer therapies and medically assisted treatments that are potentially blocked due to orphan designation. The vote, on May 11, was 250 yeas to 168 nays, with a two-thirds majority required for approval.

How area members of Congress voted last week

WASHINGTON — Here’s a look at how area members of Congress voted over the previous week. Along with the week’s roll call votes, the Senate also passed the Alaska Tourism Recovery Act (S. 593). House votes ORPHAN PRESCRIPTION DRUGS: The House has rejected the Fairness in Orphan Drug Exclusivity Act (H.R. 1629), sponsored by Rep. Madeleine Dean, D-Pa. The bill would have prevented prescription drug manufacturers who receive orphan status for a drug from the Food and Drug Administration from using the same status for a newly approved drug that has an ingredient identical to the drug that received orphan status. Dean said the change would help “ensure people can gain access to newer therapies and medically assisted treatments that are potentially blocked due to orphan designation.” The vote, on May 11, was 250 yeas to 168 nays, with a two-thirds majority required for approval.

Congressional roll call: How WNC s members of Congress voted May 7-13

WASHINGTON - Here s a look at how area members of Congress voted over the previous week. Along with the week s roll call votes, the Senate also passed the Alaska Tourism Recovery Act (S. 593). House votes House Vote 1: ORPHAN PRESCRIPTION DRUGS: The House has rejected the Fairness in Orphan Drug Exclusivity Act (H.R. 1629), sponsored by Rep. Madeleine Dean, D-Pa. The bill would have prevented prescription drug manufacturers who receive orphan status for a drug from the Food and Drug Administration from using the same status for a newly approved drug that has an ingredient identical to the drug that received orphan status. Dean said the change would help ensure people can gain access to newer therapies and medically assisted treatments that are potentially blocked due to orphan designation. The vote, on May 11, was 250 yeas to 168 nays, with a two-thirds majority required for approval.

© 2025 Vimarsana

vimarsana © 2020. All Rights Reserved.